The safety of gadolinium-based contrast agents for MRI continues to generate much controversy and discussion. As both a radiologist and a lawyer, Dr. Alexander Radbruch, JD, is well-placed to comment on the most significant recent developments in gadolinium retention in the brain, how best to use these agents, and how radiologists and manufacturers can help to avoid being sued.
The safety of gadolinium-based contrast agents for MRI continues to generate much controversy and discussion. As both a radiologist and a lawyer, Dr. Alexander Radbruch, JD, is well-placed to comment on the most significant recent developments on gadolinium retention in the brain, how best to use these agents, and how radiologists and manufacturers can help to avoid being sued.Video from ECR 2019: Alexander Radbruch on gadolinium debate
Feb 28, 2019
Latest in PACS/VNA
GE HealthCare launches Genesis portfolio on AWS Marketplace
September 23, 2025
Sectra reports sales, profit increases for Q1
September 4, 2025
Radpair partners with AdvaHealth Solutions on AI platform
August 21, 2025
MedDream launches latest version of DICOM viewer
August 13, 2025